Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
AAPS Pharmscitech|March 31, 2010
An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrineOusama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxisF Estelle R Simons, Xiaochen Gu, Norman A Silver, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 12, 2012
Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation developmentOusama Rachid, Mutasem Rawas-Qalaji, F Estelle R Simons, et al.
Expert Opinion on Drug Delivery|December 2, 2014
Drug-device combination products in the twenty-first century: epinephrine auto-injector development using human factors engineeringEric S Edwards, Evan T Edwards, F Estelle R Simons, et al.
Drug Development and Industrial Pharmacy|December 15, 2004
Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrineXiaochen Gu, Daryl J Fediuk, F Estelle R Simons, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
Allergen-specific oral immunotherapy for peanut allergyUlugbek Nurmatov, Iris Venderbosch, Graham Devereux, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2002
Clinical pharmacology of H1-antihistamines in the skinF Estelle R Simons, Norman A Silver, Xiaochen Gu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 30, 2009
Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxisMutasem Rawas-Qalaji, F Estelle R Simons, David Collins, et al.
Critical Care (London, England)|June 12, 2015
A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repairDuane J Funk, Kent T HayGlass, Joshua Koulack, et al.
Immunology|August 2, 2006
Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donorsCynthia A Ellison, Masaru Taniguchi, Jacqie M M Fischer, et al.
Pageof 16